nib appoints Hisham El-Ansary as independent Non-Executive Director

nib holdings limited (nib) (ASX: NHF) said today it has appointed Hisham El-Ansary to the nib Board.

nib Chairman David Gordon welcomed Mr El-Ansary, who joins from 2 December 2025.

Mr El-Ansary is a Non-Executive Director on the RACV Board; an adviser to Goldman Sachs, Asia Pacific; a former member of the Healthscope Advisory Board, and former Chief Executive Officer and member of the global executive team of Bupa, Asia Pacific.

In his role as CEO of Bupa Asia Pacific, and a member of Bupa’s global executive team, he led a business portfolio generating over $10 billion in revenue across Australia, New Zealand and Asia. Prior to that, he was Chief Financial and Strategy Officer for Bupa, Australia and NZ.

He has more than 30 years’ experience as a senior executive in healthcare, insurance, retail, aviation and construction consulting within Australia and the Asia Pacific region.

“Hisham brings relevant and diverse skills and experience to the nib Board, including his senior executive experiences in large commercial and healthcare businesses,” Mr Gordon said. “We look forward to working with him.”

Mr El-Ansary’s appointment reflects nib’s ongoing focus and commitment to orderly Board renewal and future Board succession planning.

Mr El-Ansary will stand for election at the 2026 Annual General Meeting. His appointment follows the retirement of Donal O’Dwyer, as a Non-Executive Director, after the nib 2025 Annual General Meeting on 6 November 2025.

This announcement has been authorised for release by Jordan French, nib Company Secretary.